Kineta Inc.
Kineta, Inc. is a clinical-stage biotechnology company with a focus on developing immunotherapies that transform patients' lives. It focuses on developing potentially differentiated immunotherapies that address the challenges with current cancer therapy. The company's immuno-oncology pipeline includes KVA12123, a VISTA blocking immunotherapy in development as a twice weekly monoclonal antibody (m… Read more
Market Cap & Net Worth: Kineta Inc. (KA)
Kineta Inc. (NASDAQ:KA) has a market capitalization of $5.89 Million ($5.89 Million) as of March 19, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #32214 globally and #10577 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Kineta Inc.'s stock price $0.48 by its total outstanding shares 12261400 (12.26 Million).
Kineta Inc. Market Cap History: 2016 to 2024
Kineta Inc.'s market capitalization history from 2016 to 2024. Data shows change from $21.05 Billion to $5.89 Million (-57.77% CAGR).
Kineta Inc. Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Kineta Inc.'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
8.18x
Kineta Inc.'s market cap is 8.18 times its annual revenue
1728.56x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2019 | $3.91 Billion | $5.00 Million | -$59.12 Million | 782.77x | N/A |
| 2020 | $1.46 Billion | $10.49 Million | -$13.88 Million | 139.12x | N/A |
| 2021 | $254.06 Million | $9.09 Million | -$11.96 Million | 27.95x | N/A |
| 2022 | $77.86 Million | $1.95 Million | -$63.07 Million | 39.87x | N/A |
| 2023 | $44.51 Million | $5.44 Million | -$14.10 Million | 8.18x | N/A |
Competitor Companies of KA by Market Capitalization
Companies near Kineta Inc. in the global market cap rankings as of March 19, 2026.
Key companies related to Kineta Inc. by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #162 globally with a market cap of $117.09 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #281 globally with a market cap of $74.80 Billion USD.
- CSL Limited (PINK:CMXHF): Ranked #344 globally with a market cap of $63.46 Billion USD.
- argenx SE (OTCGREY:ARGNF): Ranked #500 globally with a market cap of $42.99 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #162 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $117.09 Billion | $462.49 |
| #281 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $74.80 Billion | $759.05 |
| #344 | CSL Limited | PINK:CMXHF | $63.46 Billion | $149.87 |
| #500 | argenx SE | OTCGREY:ARGNF | $42.99 Billion | $697.42 |
Kineta Inc. Historical Marketcap From 2016 to 2024
Between 2016 and today, Kineta Inc.'s market cap moved from $21.05 Billion to $ 5.89 Million, with a yearly change of -57.77%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2024 | $5.89 Million | -86.77% |
| 2023 | $44.51 Million | -42.83% |
| 2022 | $77.86 Million | -69.35% |
| 2021 | $254.06 Million | -82.59% |
| 2020 | $1.46 Billion | -62.72% |
| 2019 | $3.91 Billion | -29.63% |
| 2018 | $5.56 Billion | -44.43% |
| 2017 | $10.01 Billion | -52.45% |
| 2016 | $21.05 Billion | -- |
End of Day Market Cap According to Different Sources
On Nov 19th, 2025 the market cap of Kineta Inc. was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $5.89 Million USD |
| MoneyControl | $5.89 Million USD |
| MarketWatch | $5.89 Million USD |
| marketcap.company | $5.89 Million USD |
| Reuters | $5.89 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.